HS-CRP: High Sensitivity CRP (C-reactive Protein)
WEBC-reactive protein (CRP) is an acute-phase protein produced in the liver as part of the body’s natural inflammatory response. 1,2 It is produced in greater volumes when inflammatory conditions are present, with high concentrations indicating more serious inflammation of the patient’s system. 1 CRP tests, which measure the concentration of CRP in blood plasma, are a useful non-specific ...
Hypertensive Crisis, Urgency, & Emergency - The Cardiology Advisor
WEBUpdated: 05/20/2024. A hypertensive crisis is a severe increase in blood pressure (systolic ≥180 mm Hg and/or diastolic ≥110 mm Hg). 1 Without immediate intervention, severe cases can be fatal. 1 There are 2 types of hypertensive crises: hypertensive urgency and hypertensive emergency. 1 A hypertensive urgency is a severe elevation in blood pressure in an otherwise stable patient who does ...
FFR: Fractional Flow Reserve - The Cardiology Advisor
WEBDecember 5, 2022. Fractional flow reserve (FFR) is a diagnostic cardiac catheterization technique used to measure blood flow and pressure in an isolated segment of the coronary artery. FFR is the current standard of care for the evaluation of lesions in intermediate-grade stenosis. It is more precise than non-invasive techniques in determining ...
Elevated RDW Associated With Pulmonary Hypertension, Heart …
WEBJanuary 23, 2019. Red cell distribution width (RDW) is strongly associated with multiple cardiopulmonary conditions including pulmonary arterial hypertension, congestive heart failure, and chronic pulmonary heart disease, according to study results published in the Annals of the American Thoracic Society. 1. RDW is a prognostic factor in many ...
Congestive Heart Failure Symptoms, Stages, & Classification - The ...
WEBFeb 13, 2024 · Congestive heart failure is a potentially life-threatening condition that impacts millions of people. However, patients with congestive heart failure may be asymptomatic until functional remodeling of the heart occurs. 1 In addition, heart failure is often overlooked or misdiagnosed, particularly in older adults. 2 To help health care providers increase patient awareness, this article covers ...
Cardiology News, Research Articles | Heart Disease, Disorder Studies
WEBMetabolic. Myocardial and Pericardial Disease. Pediatric Cardiology. Practice Management. Transplantation. Valvular Heart Disease. Vascular Disease. Cardiology news, research and treatment articles offering cardiology healthcare professionals cardiology informati.
Atrial Tachycardia: Diagnosis - The Cardiology Advisor
WEBDec 5, 2022 · Atrial tachycardia is a type of paroxysmal supraventricular tachycardia (PVST), a group of arrhythmias that originate above the atrioventricular junction. Atrial tachycardia can occur after an ablation for the management of atrial fibrillation. Patients presenting with atrial tachycardia may experience palpitations, lightheadedness, chest pain, or shortness of breath.
Beta Blockers in Heart Failure Management - The Cardiology Advisor
WEBFeb 12, 2024 · Beta blockers are the mainstay heart failure treatment for patients with an LVEF of up to 40%, as seen in HFrEF. 2 High-quality evidence from multiple RCTs indicates that beta blockers can boost clinical status by improving left ventricular function and reducing symptoms of heart failure, and the risk of hospitalization and mortality. 2 In ...
PCI vs CABG - The Cardiology Advisor
WEBDec 5, 2022 · Percutaneous coronary intervention (PCI) and coronary artery bypass grafting (CABG) are two options for the treatment and management of coronary artery disease. Advancements in imaging techniques, including computed tomography, magnetic resonance imaging, intravascular ultrasound, and optical coherence tomography, have improved the detection of patients’ needs for PCI vs CABG interventions.
Comparison of Risk Associated With STEMI vs NSTEMI
WEBSep 7, 2016 · Rehospitalization rates for MI and stroke as well as the composite end point between STEMI and NSTEMI patients were as follows: 6.1% vs 9.6% (P <.001), 2.7% vs 3.2% (P =.006), and 21.9% vs 27.9% (P <.001). The unadjusted rates of all end points were lower for STEMI patients compared with NSTEMI patients from 90 days to 2 years.